
欧洲主患者指数软件市场预测至 2028 年 - COVID-19 影响和按类型(软件和服务)进行区域分析;部署(基于云和本地)
No. of Pages: 96 | Report Code: TIPRE00023501 | Category: Technology, Media and Telecommunications
No. of Pages: 96 | Report Code: TIPRE00023501 | Category: Technology, Media and Telecommunications
主患者指数(MPI)是每家医院或医疗机构中心的重要组成部分。维护庞大的患者数据库使用 MPI 软件或系统。 MPI 软件或系统是电子健康记录 (HER) 中构建的主要功能,用于在组织级别维护患者的通用身份。 MPI 有助于连接多个数据库中的患者记录并减少患者的数据重复。 MPI 还有助于避免因数据不准确而导致治疗不当。
因此,基于云的技术的采用预计将在未来几年对主患者索引软件产生巨大需求,进一步预计将推动主患者索引软件市场。
该地区许多制药公司正在积极参与 COVID-19 疫苗的开发。一些人捐赠了潜在的化合物用于紧急使用和临床试验,包括以前在埃博拉等其他病毒病原体上进行过测试的化合物。许多公司利用现有技术,一旦确定了潜在的候选疫苗,就能够快速扩大生产。制药公司优先研究和开发与 COVID-19 相关的诊断、治疗、健康技术和疫苗。此外,公司和研究中心专注于利用智能技术来收集患者数据,使他们能够产生见解并做出数据驱动的决策。此外,该软件提供了高度的匿名性,允许患者行使隐私权。因此,对采用 EMR、EHR、主患者索引软件和其他技术等患者数据管理系统的偏好为预测期内欧洲主患者索引软件市场的增长提供了有利的环境。
欧洲的主患者索引软件市场预计将从2021年的2.241亿美元增长到2028年的4.333亿美元;预计 2021 年至 2028 年复合年增长率为 9.9%。医疗保健 IT 解决方案正在推动医疗保健领域的大规模创新,有助于提高服务质量。远程医疗、移动医疗、远程患者监护、行为健康技术和消费者驱动的数字健康等技术极大地改变了护理服务的基础。对这些进步的积极展望和接受可能会鼓励公司在未来开发更多 MPI 软件。基础设施的发展以及自动化医疗保健 IT 解决方案的采用吸引了政府对医疗保健数字化的支持和投资。例如,2017年3月,苏格兰NHS与Wipro Limited签署了为期12年的合同,开发下一代EMPI解决方案,预计将通过其传统的社区健康指数(CHI)系统实现苏格兰医疗保健系统的转型,在医疗保健服务中实现无纸化、经济高效、高效且患者友好的 MPI 软件。同样,根据欧盟 (EU) 2019 年数据,欧盟为法国创建 MPI 捐款 220,474 美元(180,000 欧元)。此外,COVID-19 大流行需要额外投资来建立数字医疗保健。医疗保健领域流程的数字化正在成为一个显着趋势,这将推动预测期内 MPI 软件的采用。
从类型来看,软件细分市场在2020年欧洲主患者指数软件市场中占据最大份额。从部署来看,基于云的细分市场2020年在主患者索引软件市场中占有更大的市场份额。
准备本欧洲主患者索引软件市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 McKESSON CORPORATION、Oracle Corporation、Wipro Limited、Allscripts Healthcare Solutions, Inc.、NextGate、MEDITECH 和 Intersystems Corporation。
按类型
通过部署
按国家/地区
Strategic insights for Europe Master Patient Index Software involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 224.1 Million |
Market Size by 2028 | US$ 433.3 Million |
Global CAGR (2021 - 2028) | 9.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Master Patient Index Software refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Master Patient Index Software Market is valued at US$ 224.1 Million in 2021, it is projected to reach US$ 433.3 Million by 2028.
As per our report Europe Master Patient Index Software Market, the market size is valued at US$ 224.1 Million in 2021, projecting it to reach US$ 433.3 Million by 2028. This translates to a CAGR of approximately 9.9% during the forecast period.
The Europe Master Patient Index Software Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Master Patient Index Software Market report:
The Europe Master Patient Index Software Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Master Patient Index Software Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Master Patient Index Software Market value chain can benefit from the information contained in a comprehensive market report.